Kate Dellorusso
Stock Analyst at LifeSci Capital
(2.86)
# 2,897
Out of 4,659 analysts
25
Total ratings
56.3%
Success rate
8.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kate Dellorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MREO Mereo BioPharma Group | Maintained: Hold | n/a | $0.313 | - | 4 | Aug 15, 2026 | |
| UPB Upstream Bio | Maintained: Buy | $19 | $6.85 | +177.37% | 13 | Aug 15, 2026 | |
| ACRS Aclaris Therapeutics | Maintained: Buy | $13 | $6.31 | +106.19% | 2 | Aug 6, 2026 | |
| CRNX Crinetics Pharmaceuticals | Maintained: Hold | $85 | $84.72 | +0.33% | 6 | Jul 11, 2026 |
Mereo BioPharma Group
Aug 15, 2026
Maintained: Hold
Price Target: n/a
Current: $0.313
Upside: -
Upstream Bio
Aug 15, 2026
Maintained: Buy
Price Target: $19
Current: $6.85
Upside: +177.37%
Aclaris Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $13
Current: $6.31
Upside: +106.19%
Crinetics Pharmaceuticals
Jul 11, 2026
Maintained: Hold
Price Target: $85
Current: $84.72
Upside: +0.33%